Skip to main content
Erschienen in: Rheumatology International 5/2013

01.05.2013 | Original Article

The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype

verfasst von: Paola Caramaschi, Domenico Biasi, Cristian Caimmi, Cinzia Scambi, Sara Pieropan, Giovanni Barausse, Silvano Adami

Erschienen in: Rheumatology International | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

To evaluate in a cohort of 100 consecutive patients affected by primary Sjogren’s syndrome (pSS) the incidence of Hashimoto thyroiditis (HT) and to compare the clinical features and the laboratory parameters of patients affected by pSS with and without concomitant HT. In 100 consecutive patients affected by pSS, the occurrence of other autoimmune diseases was recorded and a full examination of thyroid function obtained. HT was associated with pSS in 27 cases. The comparison between pSS cases with and without HT showed that only patients with isolated pSS had low C4 level [p = 0.032, OR (IC 95 %) 230 (13.13–4,046)]. In addition, only patients affected by pSS without HT had evidence of cryoglobulins, cutaneous vasculitis with palpable purpura, peripheral neuropathy, and development of lymphoma, although all these manifestations were observed in a 4.1–8.2 % of the cases, without reaching statistical significance. The association of HT in patients suffering from pSS defines a subset of patients with milder disease and normal C4 levels.
Literatur
1.
Zurück zum Zitat Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid 19:39–45PubMedCrossRef Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid 19:39–45PubMedCrossRef
2.
Zurück zum Zitat D’Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthr Care Res 49:804–809CrossRef D’Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthr Care Res 49:804–809CrossRef
3.
Zurück zum Zitat Horvath IF, Szodoray P, Zeher M (2008) Primary Sjogren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 27:1479–1483PubMedCrossRef Horvath IF, Szodoray P, Zeher M (2008) Primary Sjogren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 27:1479–1483PubMedCrossRef
4.
Zurück zum Zitat Ramos-Casals M, Garcia-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, Aymamí A, Morlà RM, Font J, Ingelmo M (2000) Thyroid disease in primary Sjogren’s syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79:103–108CrossRef Ramos-Casals M, Garcia-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, Aymamí A, Morlà RM, Font J, Ingelmo M (2000) Thyroid disease in primary Sjogren’s syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79:103–108CrossRef
5.
Zurück zum Zitat Orgiazzi J (1999) The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne (Paris) 150:294–300 Orgiazzi J (1999) The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne (Paris) 150:294–300
6.
Zurück zum Zitat Jara LJ, Navarro C, Brito-Zeron MP, Garcia-Carrasco M, Escarcega RO, Ramos-Casals M (2007) Thyroid disease in Sjogren’s syndrome. Clin Rheumatol 26:1601–1606PubMedCrossRef Jara LJ, Navarro C, Brito-Zeron MP, Garcia-Carrasco M, Escarcega RO, Ramos-Casals M (2007) Thyroid disease in Sjogren’s syndrome. Clin Rheumatol 26:1601–1606PubMedCrossRef
7.
Zurück zum Zitat Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119PubMedCrossRef Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119PubMedCrossRef
8.
Zurück zum Zitat Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I (1993) Linkage studies of HLA and primary Sjogren’s syndrome in multicase families. Arthr Rheum 36:473–484CrossRef Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I (1993) Linkage studies of HLA and primary Sjogren’s syndrome in multicase families. Arthr Rheum 36:473–484CrossRef
9.
Zurück zum Zitat Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjogren’s disease and Hashimoto’s autoimmune thyroiditis. Pathologe 17:289–295PubMedCrossRef Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjogren’s disease and Hashimoto’s autoimmune thyroiditis. Pathologe 17:289–295PubMedCrossRef
10.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef
11.
Zurück zum Zitat Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthr Rheum 23:581–590CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthr Rheum 23:581–590CrossRef
12.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luhtra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luhtra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef
13.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef
14.
Zurück zum Zitat Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef
15.
Zurück zum Zitat Higgins JPT, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; section 8. In: The Cochrane library, issue 3. Wiley, Chichester Higgins JPT, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; section 8. In: The Cochrane library, issue 3. Wiley, Chichester
16.
Zurück zum Zitat Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef
17.
Zurück zum Zitat Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM (2007) Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27:407–410PubMedCrossRef Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM (2007) Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27:407–410PubMedCrossRef
18.
Zurück zum Zitat Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthr Rheum 46:741–747CrossRef Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthr Rheum 46:741–747CrossRef
19.
Zurück zum Zitat Ramos-Casals M, Brito-Zeron P, Yaque J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology 44:89–94PubMedCrossRef Ramos-Casals M, Brito-Zeron P, Yaque J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology 44:89–94PubMedCrossRef
20.
Zurück zum Zitat Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 37:608–614PubMedCrossRef Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 37:608–614PubMedCrossRef
21.
Zurück zum Zitat Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, Gambari PF (1996) Thyroid gland disorders in primary Sjögren’s syndrome. Rev Rhum 63:809–814 Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, Gambari PF (1996) Thyroid gland disorders in primary Sjögren’s syndrome. Rev Rhum 63:809–814
Metadaten
Titel
The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype
verfasst von
Paola Caramaschi
Domenico Biasi
Cristian Caimmi
Cinzia Scambi
Sara Pieropan
Giovanni Barausse
Silvano Adami
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2570-6

Weitere Artikel der Ausgabe 5/2013

Rheumatology International 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.